Liver disease is an important cause of morbidity and mortality in the United States, affecting persons of all ages, but most frequently individuals in the productive years of life, between the ages of 40 and 60 years.
Liver disease also disproportionately affects minority individuals and the economically disadvantaged.
Medical research on liver disease is critically important and further progress in research promises to bring under control the major toll of liver disease on human health and well-being.
Indeed, the last 25 years of medical research in liver disease has resulted in major improvements in the survival and quality-of-life of patients with liver disease.
|Action Plan for Liver Disease Research is set up to advance research on liver disease with the aim of decreasing the burden of liver disease in the USA|
The next 25 years should bring even more profound and important changes.
To address the burden of liver diseases in the United States, the National Institutes of Health is developing an Action Plan for Liver Disease Research.
NIH created a Liver Disease Research Branch (LDRB) in the NIDDK and established a Liver Disease Subcommittee of the Digestive Diseases Interagency Coordinating Committee.
This is a congressionally mandated committee responsible for coordination of digestive disease research activities among components of the NIH and other federal agencies.
Their mission statement:
The goal of the Action Plan for Liver Disease Research will be to advance research on liver disease with the aim of decreasing the burden of liver disease in the United States.